Vimedimex Medi-Pharma Joint Stock Company

HOSE:VMD Stock Report

Market Cap: ₫256.3b

Vimedimex Medi-Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Pham Sen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5yrs
CEO ownershipn/a
Management average tenure4.2yrs
Board average tenure2.6yrs

Recent management updates

Recent updates


CEO

Pham Sen

5yrs

Tenure

Ms. Pham Thi Sen has been Chief Executive Officer of Vimedimex Medi-Pharma Joint Stock Company since January 1, 2020 and was its Deputy Chief Executive Officer since March 1, 2018 until January 1, 2020.


Leadership Team

NamePositionTenureCompensationOwnership
Pham Sen
Chief Executive Officer5yrsno datano data
Dung Thu Nguyen
Chief Accountant1.2yrsno datano data
Quan Pham
Deputy Chief Executive Officer1.9yrsno datano data
Duyen Trinh
Deputy Chief Executive Officer4.3yrsno datano data
Tran Linh
Deputy CEO & Director4.7yrsno datano data
Son Le
Deputy Chief Executive Officer4.4yrsno datano data
Van Ta
Deputy Chief Executive Officer4.3yrsno datano data
Duc Nguyen
Deputy Chief Executive Officer4.2yrsno datano data
Mai Nguyen Thi
Deputy Chief Executive Officer3.4yrsno datano data
Hong Nguyen
Deputy CEO2.7yrsno datano data
Anh Nguyen
Deputy Chief Executive Officer1.3yrsno datano data

4.2yrs

Average Tenure

Experienced Management: VMD's management team is considered experienced (4.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Tran Linh
Deputy CEO & Director2.6yrsno datano data
Bach Chinh
Directorno datano datano data
Tran Doan Trang
Director7.6yrsno datano data
Nguyen Hung
Director7.6yrsno datano data
Le Dung
Director7.6yrsno datano data
Nguyen Quang
Non-Executive Directorno datano datano data
Tung Le
Chairman2.6yrsno datano data
Giang Doan
Member of the Board of Supervisors2.6yrsno datano data
Giang Trinh
Director2.1yrsno datano data
Cuong Tran
Member of the Supervisory Boardless than a yearno datano data
Dung Nguyen
Directorless than a yearno datano data

2.6yrs

Average Tenure

Experienced Board: VMD's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/17 08:27
End of Day Share Price 2025/01/17 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vimedimex Medi-Pharma Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution